Friday April 1st

13:00
13:05

Session 1 - Selected poster presentations

13:05
14:30

14:30
15:00

Keynote Lecture
A systems biology view on agerelated macula degeneration

15:00
15:45

Coffee break

Session 2 - Factors shape the efficiency of gene therapy

15:45
16:10

Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment, success and safety 

16:10
16:35

AAV-mediated retinal pathology in mice is connected to reactive microgliosis

16:35
17:00

AAV vectors and CRISPRa-Cas9- based (epi)genome editing approaches for retinal gene therapy

17:00
17:25

Microglia during retinal degeneration

17:25

Dinner

19:00
19:30

Evening Lecture
Current strategies for the inhibition of myopia 

19:30
open end

Swingin´ Poster Session

Saturday April 2nd

Session 3 - The role of metabolic homeostasis and mitochondria in retinal diseases

09:00
09:25

Metabolic aspects of retinal degeneration

Stelios Michalakis
Munich, Germany

09:25
09:50

Mitochondrial Retinopathy

Johannes Birtel
Bonn, Germany/Oxford, UK

09:50
10:15

 CERKL, a retinal dystrophy gene, regulates mitochondrial function and dynamics in the mammalian retina

Gemma Marfany
Barcelona, Spain

10:15
10:40

Serine metabolism in the retina

Marcus Fruttiger
London, UK

10:40
11:05

Lipid metabolism in RPE

Christian Grimm
Zurich, Switzerland

11:05
11:40

Coffee break

Session 4 - Factors shaping photoreceptor environment

11:40
12:05

Incorporation, polarisation and maturation of human photoreceptors transplanted into mouse models of retinal degeneration

Marius Adler
Dresden, Germany

12:05
12:30

Using iPSC-derived retinal models to understand and treat inherited retinal diseases

Vasiliki Kalatzis
Montpellier, France

12:30
12:55

AMD 10q26 risk haplotype impairs subretinal monocyte elimination

Christophe Roubeix
Roche – Basel, Switzerland

12:55
13:00

Concluding remarks

13:00

Lunch and end of meeting